Pediatric Endocrinology
Adalbert Raimann
DDr. Adalbert Raimann is a pediatrician at the Medical University of Vienna, Austria. He completed his medical studies in 2011 with distinction and subsequently completed his specialist training in pediatric and adolescent medicine. In 2021, Dr. Raimann obtained his additional qualification in pediatric endocrinology and diabetology.
DDr. Raimann's clinical interests include rare hormonal disorders as well as disorders of calcium and phosphate metabolism, primary osteoporosis/osteogenesis imperfecta, and secondary pediatric osteoporosis.
He is a member of numerous international associations and has published a wide variety of research articles on his clinical interests. He is also a member of the research groups for pediatric endocrinology and osteology and of the Vienna Center for Bone and Growth.
Professional Activity
- Specialist physician at the Children's Hospital AKH Vienna
- Outpatient clinic for pediatric endocrinology and osteology
Postgraduate Training
- Harvard Medical School / MassGen Boston, USA
- Doctorate of Medical Sciences, Medical University of Vienna
MD Human Medicine
- Medical University of Vienna
- Karolinska Institutet, Stockholm, Sweden
Professional Society Memberships
- Working Group for Pediatric Endocrinology and Diabetology APEDÖ (https://www.paediatrie.at/arbeitsgruppen-und-referate/leiter-ag/ag-endokrinologie-und-diabetologie)
- International Society for Children's Bone Health ISCBH (https://theiscbh.org/)
- European Society of Pediatric Endocrinology ESPE (https://www.eurospe.org/)
- Austrian Society for Pediatric and Adolescent Medicine ÖGKJ (https://www.paediatrie.at/)
- Austrian Society for Bone and Mineral Metabolism ÖGKM (https://www.oegkm.at/)
- European Calcified Tissue Society ECTS (https://ectsoc.org/)
- Austrian Society for Internal Medicine ÖGIM (https://www.oegim.at/)
Publication: Osteoporosis in Childhood and Adolescence — Austrian Journal of Clinical Endocrinology, Diabetology and Metabolism
Osteoporosis is a disease of the skeletal system that leads to an increased rate of bone fractures due to impairment of the bone microarchitecture. While osteoporosis in older adults is a common diagnosis, childhood and adolescent osteoporosis has only been given increasing attention for a relatively short time.
Publication: Multidisciplinary Care of XLH — Wiener Med Monatssschrift
X‑linked hypophosphatemic rickets (XLH, OMIM #307800) is a rare genetic metabolic disorder caused by dysregulation of fibroblast-like growth factor 23 (FGF23) leading to profound reduction in renal phosphate reabsorption. Impaired growth, severe rickets and complex skeletal deformities are direct consequences of hypophosphatemia representing major symptoms of XLH during childhood. In adults, secondary complications including early development of osteoarthritis substantially impair quality of life and cause significant clinical burden.
Publication: Bone Changes in Chronic Diseases in Childhood — Curr Osteoporos Rep
Metabolic and genetic bone disorders affect not only bone mass but often also the bone material, including degree of mineralization, matrix organization, and lacunar porosity. The quality of juvenile bone is moreover highly influenced by skeletal growth. This review aims to provide a compact summary of the present knowledge on the complex interplay between bone modeling and remodeling during skeletal growth and to alert the reader to the complexity of bone tissue characteristics in children with bone disorders.